A cross-circulatory platform for monitoring innate allo-responses in lung grafts.

A cross-circulatory platform for monitoring innate allo-responses in lung grafts.

Lung transplantation is the only curative option for end-stage chronic respiratory diseases. However the survival rate is only about 50% at 5 years. Although experimental evidences have shown that innate allo-responses impact on the clinical outcome, the knowledge of the involved mechanisms involved...

Full description

Bibliographic Details
Main Authors: Matthieu Glorion, Florentina Pascale, Jérôme Estephan, Maxime Huriet, Carla Gouin, Céline Urien, Fany Blanc, Julie Rivière, Christophe Richard, Valérie Gelin, Julien De Wolf, Morgan Le Guen, Antoine Magnan, Antoine Roux, Isabelle Schwartz-Cornil, Edouard Sage
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0285724

Internet

https://doi.org/10.1371/journal.pone.0285724

Similar Items